13
Timepoint/Frequency of Testing
Every 6
Months
Every 12
Months
Treatment
Failure
Clinically
Indicated
If ART
Initiation is
Delayed
c
Aer 2 years on
ART
with consistently
suppressed viral
load:
CD4 Count
300–500
cells/mm
3
:
• Every 12 mos
CD4 Count
>500 cells/mm
3
:
• CD4
monitoring is
optional
Every 3–6
months
e
Repeat
testing is
optional
f
If considering a
CCR5 antagonist
or for failure of
CCR5 antagonist-
based regimen
May repeat if
patient
non-immune
and not
chronically
infected
with HBV
h
Including
prior to
starting
HCV
DAA
